drugset / Trial / NCT07659132

Fospropofol Disodium Versus Propofol for Patient Satisfaction in Ureteroscopy

NCT07659132

Phase 4 Not yet recruiting 190 enrolled Shiyou Wei
RandomizedParallel-groupSingle-blindTreatment

Summary

This single-center single-blind randomized trial compares fospropofol disodium and propofol for anesthesia in elective ureteroscopy patients. A total of 190 eligible adults will be randomly divided into two groups at 1:1 ratio with identical intraoperative maintenance protocols. The primary outcome is 24-hour postoperative anesthesia satisfaction assessed by ISAS scale; secondary and safety endpoints include injection pain, intraoperative hemodynamic events and various perioperative adverse reactions. This study explores the clinical efficacy and safety of the two sedatives to guide rational clinical medication.

Timeline

Start
2026-06-26
Primary completion
2026-09-25
Completion
2026-09-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule Intravenous
Subject fospropofol Small molecule Intravenous
Background Sufentanil Other / unclassified Intravenous

Indications